SS-31 10mg

Elamipretide Research Peptide is the research community's shorthand for SS-31 - the same compound listed on this page. If you searched for Elamipretide Research Peptide, Elamipretide, Bendavia, SS31, this is that compound: SS-31 supplied as a 10mg lyophilised vial, third-party tested with a batch-specific Certificate of Analysis. For in-vitro research use only.

SS-31 is a synthetic peptide supplied by Pillar Research as Lyophilised powder for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. In research communities it is also searched for as Elamipretide, Bendavia, SS31 - all refer to the same compound.

Studied for how the energy centres of cells behave in laboratory models. More precisely, binding to cardiolipin directly on the inner mitochondrial membrane - a different mechanism class from the receptor-mediated peptides studied elsewhere in the range. SS-31 is supplied strictly as Research Use Only material for in-vitro laboratory work.

Studied for how the energy centres of cells behave - particularly in heart and skeletal muscle. More precisely, mitochondrial function, cellular energy production, and oxidative-stress markers in tissues with high mitochondrial density.

SS-31 is commonly referred to as Elamipretide Research Peptide in research communities and is sometimes searched for as Elamipretide, Bendavia, SS31 - all refer to the same compound.

Unlike most compounds in this catalogue, SS-31 (Elamipretide) does not act through a cell-surface receptor - it binds cardiolipin directly on the inner mitochondrial membrane, a different mechanism class from the GPCR-mediated peptides studied elsewhere in Pillar Research's range.

You are looking at the evidence the same way researchers do: by compound, batch and method, not by marketing claim. SS-31 is supplied as a research-use compound for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. Each Pillar Research batch is third-party tested by HPLC and mass spectrometry, with the batch-specific Certificate of Analysis published for review before ordering - that certificate is the research record to judge.

Pillar Research does not provide dosing, reconstitution-for-use, or administration guidance for any compound - this is a deliberate policy, not an oversight, consistent with the Research Use Only framework under which SS-31 is supplied. Research protocols vary by study design and institution. Consult the peer-reviewed literature for the compound (see the references linked on this page) or a qualified research supervisor for protocol-specific guidance.

SS-31 (10mg) is available through Pillar Research, a trusted supplier for research peptides, with fast domestic shipping to all states and territories. Every vial is dispatched from domestic Australian stock the same business day - no customs delays, no international freight uncertainty. The batch-specific Certificate of Analysis is available to review before ordering. See our supplier guide at /buy-peptides-australia for the checklist to apply to any Australian supplier.

Pillar Research does. Each SS-31 batch is tested by Janoshik Analytical, an independent third-party laboratory, and the batch-specific Certificate of Analysis is published on this page before you order. Stock is held in Australia and dispatched with dispatch in an estimated 1-2 weeks.

SS-31 (10mg) is priced at A$109.99 per vial at Pillar Research. SS-31 is open for preorder now. Orders dispatch in an estimated 1-2 weeks. Batch Certificates of Analysis are available in our CoA library.

SS-31 is a research-use compound supplied for lawful in-vitro laboratory research under the Research Use Only (RUO) framework. Purchasers confirm the compound is intended for in-vitro research use at checkout.

Ordering is straightforward - add SS-31 10mg (Elamipretide Research Peptide) to your cart on this page and complete checkout. All orders are fulfilled from domestic Australian stock and shipped with tracking; dispatch in an estimated 1-2 weeks. A batch-specific Certificate of Analysis is included with every order.

Yes. Each released SS-31 10mg (Elamipretide Research Peptide) vial is linked to a batch-specific Certificate of Analysis (COA) so the stated purity, identity and batch record can be reviewed before ordering. SS-31 10mg (Elamipretide Research Peptide) is listed at 99.819% purity. Each released batch is independently analysed by HPLC for chromatographic purity and by mass spectrometry for identity.

SS-31 binds cardiolipin directly on the inner mitochondrial membrane, while NAD+ is a coenzyme studied for cellular energy metabolism - different mechanism classes within mitochondrial research. SS-31 is particularly studied in tissues with high mitochondrial density such as heart and skeletal muscle. All material is for in-vitro laboratory research use only.

No. SS-31 is not listed on the Australian Register of Therapeutic Goods (ARTG), so it is not stocked by Australian retail pharmacies and is not a therapeutic good under the Therapeutic Goods Act 1989 (Cth). Compounding pharmacies cannot supply it either - there is no approved commercial or pharmacy release to compound from. Pillar Research supplies it as Research Use Only material for in-vitro laboratory work, not for human or animal use, and it should not be sought as a consumer product.

SS-31 may be lawfully supplied and held in Australia as Research Use Only material for in-vitro laboratory and educational research. That is a different status from approval for human use, which it does not have. Purchasers confirm they are a qualified researcher or acting for a licensed research facility, and are responsible for the lawful handling, storage and use of the material.